Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02314702

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
26 (actual)
Sponsor
MicroPort Orthopedics Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

MicroPort Orthopedics (MPO) is conducting this PMCF study to evaluate the safety and efficacy of its THA and resurfacing components marketed in the EU. These types of studies are required by regulatory authorities for all THA and resurfacing devices that do not have medium to long-term clinical evidence available at the time of gaining approval to market in the EU. This study has been designed in accordance with MEDDEV 2.12/2 rev 2.

Conditions

Interventions

TypeNameDescription
DEVICEPROFEMUR® L Revision Femoral StemRevision Total Hip Arthroplasty

Timeline

Start date
2015-09-04
Primary completion
2026-10-01
Completion
2027-10-01
First posted
2014-12-11
Last updated
2022-10-13

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02314702. Inclusion in this directory is not an endorsement.